Co-Diagnostics, Inc. to Participate in Trade Mission to South Korea and Japan
Co-Diagnostics, Inc. (Nasdaq-CM: CODX), a leading company in the molecular diagnostics field, is excited to announce its involvement in an important trade mission. Organized by the World Trade Center Utah, this mission aims to strengthen international relationships and increase business opportunities in South Korea and Japan.
Highlighting Life Sciences and Innovation
As part of this trade delegation, Co-Diagnostics is passionate about broadening its global partnerships. The company has previously established a joint venture called CoSara Diagnostics Pvt. Ltd. in India. Throughout the pandemic, Co-Diagnostics built an impressive network of distributors and partners across more than 50 countries, successfully distributing millions of COVID-19 PCR tests around the globe.
Growing International Presence
The upcoming mission will feature meetings with industry leaders in a region that Co-Diagnostics sees as vital for its future. The company is keen to launch a new PCR diagnostic platform tailored for home use and point-of-care settings.
CEO's Commitment to Enhancing Access to Care
Dwight Egan, the Chief Executive Officer of Co-Diagnostics, highlighted the significance of creating a global network to boost healthcare access. He is enthusiastic about participating in this trade mission, as it aligns with the company's focus on improving the availability and accessibility of top-quality PCR diagnostics.
About Co-Diagnostics, Inc.
Based in Utah, Co-Diagnostics, Inc. specializes in the development, manufacturing, and marketing of innovative diagnostic technologies. The company's advancements center around the detection and analysis of nucleic acid molecules, serving various applications beyond just infectious diseases.
Frequently Asked Questions
What is the purpose of the trade mission?
The mission focuses on strengthening international relationships and exploring new business opportunities in South Korea and Japan.
What is Co-Diagnostics, Inc. known for?
Co-Diagnostics is recognized for its state-of-the-art molecular diagnostics technologies and significant contributions to the global distribution of COVID-19 tests.
Who is leading the delegation for this trade mission?
The delegation will be led by representatives from the World Trade Center Utah, along with officials from the state of Utah.
What innovations is Co-Diagnostics planning to introduce?
During the trade mission, Co-Diagnostics aims to launch a new PCR diagnostic platform designed for home and point-of-care use.
Why is global networking important for Co-Diagnostics?
Building a global network is crucial for Co-Diagnostics to improve healthcare access and enhance the distribution of reliable diagnostic solutions worldwide.
